Home › Products › Oncology › Tibsovo 200mg Tablet

Tibsovo 200mg Tablet

Salt Composition: IVOSIDENIB

₹553000.00₹657720.00

Inclusive of all taxes

Tibsovo 200mg Tablet

Categories: Oncology

Conditions: Anti Cancer

Product Introduction

Tibsovo 200mg Tablet contains Ivosidenib, an anticancer medication that belongs to the class of isocitrate dehydrogenase-1 (IDH1) inhibitors. This Tibsovo 200mg tablet is prescribed to treat certain types of cancer caused by an IDH1 gene mutation and is widely used as a targeted therapy. It is primarily indicated for acute myeloid leukaemia (AML) in adults whose cancer cells carry the IDH1 mutation, making Tibsovo for leukaemia treatment an important therapeutic option. Doctors may also recommend it for patients with cholangiocarcinoma (bile duct cancer) that has spread or cannot be surgically removed. Many people search for Tibsovo tablet uses, Tibsovo dosage, and Tibsovo side effects to learn more about this medication and its role in cancer treatment. Tibsovo works by inhibiting the abnormal IDH1 enzyme, which plays a key role in the growth and survival of cancer cells. By blocking this enzyme, the medicine helps slow down or stop the progression of cancer. Before beginning therapy, inform your doctor if you have any history of heart disease, liver disorders, or electrolyte imbalances. Your healthcare provider may recommend regular blood tests and ECG monitoring throughout the treatment period. Be sure to disclose all medications you are taking, as certain drugs may interact with Tibsovo. Patients may also search for information about the Tibsovo manufacturer and the availability of a Tibsovo generic alternative, based on their doctor's treatment recommendations.

Uses

Tibsovo tablet is used to treat: Acute myeloid leukaemia (AML) with an IDH1 mutation. Cholangiocarcinoma (bile duct cancer) with an IDH1 mutation.

How it works

Tibsovo 200mg Tablet works by inhibiting the mutant IDH1 enzyme found in certain cancer cells. This abnormal enzyme produces harmful substances that block normal cell development. By blocking the mutated IDH1 enzyme, the medicine helps restore normal cell maturation and reduces the growth and spread of cancer cells.

Side Effects

Like all medicines, Tibsovo 200mg Tablet may cause side effects, although not everyone experiences them. Common Side Effects Fatigue Joint pain Diarrhoea Nausea or vomiting Loss of appetite Abdominal pain Fever Shortness of breath Rare but Serious Side Effects Irregular heartbeat Severe swelling or weight gain Differentiation syndrome (fever, breathing problems, fluid build-up) Severe dizziness Liver problems Contact your doctor immediately if any serious side effects occur.

Expert Tips

Take Tibsovo exactly as prescribed by your doctor. Inform your doctor if you have heart disease or an abnormal heart rhythm. Attend all scheduled blood tests and medical check-ups during treatment. Avoid missing doses to ensure effective treatment. Inform your doctor about all medicines you are taking before starting therapy.

References

  1. https://www.tibsovo.com/
  2. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211192_s008lbl.pdf
  3. https://www.news-medical.net/drugs/Tibsovo.aspx

Safety Advice

Pregnancy: Consult Your Doctor Tibsovo 200mg Tablet may harm the unborn baby. Women who are pregnant or planning pregnancy should consult their doctor before using this medicine.

Lungs: Consult Your Doctor Suppose you have a pre-existing lung condition or are concerned about the safety of the Tibsovo 200mg Tablet in your lungs. Consulting with your healthcare provider for personalized advice is recommended in that case.

Breastfeeding: Unsafe Do not breastfeed while taking Tibsovo and for at least 1 month after the last dose, as the medicine may pass into breast milk.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS